Overview

Study of Outcome and Safety of Lithium, Divalproex and Risperidone for Mania in Children and Adolescents

Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the effectiveness of the medications, lithium (Eskalith®), valproate (Depakote®), and risperidone (Risperdal®) in treating children and adolescents with bipolar disorder or symptoms of mania.
Phase:
Phase 3
Details
Lead Sponsor:
Washington University School of Medicine
Collaborator:
National Institute of Mental Health (NIMH)
Treatments:
Lithium Carbonate
Risperidone
Valproic Acid